Oncology Drug Developer Jeff Geschwind, MD founded Cage Pharma. His work focuses on innovative cancer drugs that target tumor metabolism, aiming to disrupt the energy source of cancerous cells. https://www.linkedin.com/in/jeff-geschwind-037200174